WallStSmart

BRBI BR Partners S.A. ADSs (BRBI)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates -20233% more annual revenue ($2.33T vs $-11.58B). NMR leads profitability with a 17.3% profit margin vs 0.0%. NMR trades at a lower P/E of 12.8x. NMR earns a higher WallStSmart Score of 84/100 (A-).

BRBI

Hold

45

out of 100

Grade: D+

Growth: 4.7Profit: 6.5Value: 5.3Quality: 4.0
Piotroski: 3/9

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRBI3 strengths · Avg: 9.0/10
Operating MarginProfitability
32.1%10/10

Strong operational efficiency at 32.1%

Return on EquityProfitability
22.1%9/10

Every $100 of equity generates 22 in profit

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

BRBI4 concerns · Avg: 3.3/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Market CapQuality
$293.99M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BRBI

The strongest argument for BRBI centers on Operating Margin, Return on Equity, Price/Book.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : BRBI

The primary concerns for BRBI are P/E Ratio, Market Cap, Profit Margin.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

BRBI profiles as a value stock while NMR is a growth play — different risk/reward profiles.

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 45/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BRBI BR Partners S.A. ADSs

FINANCIAL SERVICES · CAPITAL MARKETS · USA

BRBI BR Partners S.A., is an investment bank that specializes in providing financial services for entrepreneurs and families in Brazil. The company is headquartered in So Paulo, Brazil.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?